Cart
sales@molnova.com
JQ1-VHL-PROTAC
CAS No. ——
JQ1-VHL-PROTAC( —— )
Catalog No. M16953 CAS No. ——
JQ1-VHL-PROTAC is a novel PROTAC synthesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameJQ1-VHL-PROTAC
-
NoteResearch use only, not for human use.
-
Brief DescriptionJQ1-VHL-PROTAC is a novel PROTAC synthesis.
-
DescriptionJQ1-VHL-PROTAC is a novel PROTAC synthesis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPROTACs
-
TargetPROTAC
-
RecptorPROTAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight1053.696
-
Molecular FormulaC51H61ClN12O7S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(2S,4R)-1-((2S)-2-(3-((1-(2-(2-(2-((6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetamido)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)methoxy)propanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Savitski MM, et al. Cell. 2018 Mar 22;173(1):260-274.e25.
molnova catalog
related products
-
Gefitinib-based PROT...
Gefitinib-based PROTAC 3 is a VHL-recruiting PROTAC that induces the degradation of EGFR and EGFR mutants with DC50 of 11.7 nM and 22.3 nM for HCC827 cell (Exon 19 del) and H3255 cell (L858R).
-
THAL-SNS-032
THAL-SNS-032 is a novel CDK9 degrader PROTAC consisting of a CDK-binding SNS-032 ligand linked to a thalidomide derivative that binds the E3 ubiquitin ligase Cereblon (CRBN).
-
TL13-12
TL13-12 is a novel Anaplastic Lymphoma Kinase (ALK)-PROTAC developed through conjugation of TAE684 and the cereblon ligand pomalidomide.
